🇺🇸 FDA
Patent

US 12156912

Methods and compositions for inhibiting diseases of the central nervous system

granted A61KA61K2039/555A61K38/1709

Quick answer

US patent 12156912 (Methods and compositions for inhibiting diseases of the central nervous system) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/555, A61K38/1709, A61K38/193, A61K38/2278